Hypoparathyroidism Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RANI | A | Rani Therapeutics Holdings, Inc. | 16.86 | |
ENTX | B | Entera Bio Ltd. | -11.16 |
Related Industries: Biotechnology
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 18 | ENTX | Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today |
- Hypoparathyroidism
Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This can lead to low levels of calcium in the blood, often causing cramping and twitching of muscles or tetany (involuntary muscle contraction), and several other symptoms. It is a very rare disease. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The diagnosis is made with blood tests, and other investigations such as genetic testing depending on the results. The primary treatment of hypoparathyroidism is calcium and vitamin D supplementation. Calcium replacement or vitamin D can ameliorate the symptoms but can increase the risk of kidney stones and chronic kidney disease. However teriparatide, brand name Forteo, a biosimilar peptide to parathyroid hormone, may be given by injection.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles